Detail

Study ID: Abbott CRD 826 Guide HF Trial

Title:

Evaluate expanding the indication of the CardioMEMS™ Heart Failure System to NYHA Class II, III, and IV patients with either a prior HF hospitalization or an elevated BNP.

Description:
Title: Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF). Description: This FDA Investigational Device Exemption (IDE) trial is intended to demonstrate clinical efficacy of the CardioMEMS™ HF System in NYHA Class II, III, IV HF patients with elevated NT-proBNP (or BNP) and/or a history of a previous HF hospitalization. This trial aims to expand its current FDA-approved indication, NYHA Class III HF patients with a HF hospitalization in the past 12 months.
Location:
Sioux Falls Region
Principal Investigator:
Orvar Jonsson, MD
Disease:
Heart
Stage:
IDE
Status:
Active - Open to Accrual